WADE ACKERMAN
Partner; Co-Lead, Digital Health Industry Group
Covington & Burling LLP
Through more than two decades of experience in private practice and positions within the FDA and on the Hill, Wade Ackerman has acquired unique insights into the evolving legal and regulatory landscape facing companies marketing FDA-regulated products.
Ackerman provides clients with advice around complex regulatory issues that demand coordinated legal, regulatory, and public policy strategies. He also serves as one of the leaders of Covington’s multidisciplinary Digital Health Initiative, which brings together the firm’s considerable resources across the broad array of legal, regulatory, commercial and policy issues relating to the development and marketing of innovative digital health technologies. He also served as senior FDA counsel to the US Senate Health Education, Labor & Pensions Committee.
